Chery Automobile's robotics division, AiMOGA Robotics, is preparing for a potential initial public offering as the Chinese automaker seeks to turn humanoid and service robots into a major new growth business and expand its presence in overseas markets.

AiMOGA's management has begun discussions about possible IPO destinations, although the company has not disclosed a listing venue or timetable. The unit was founded in January 2025 and has already delivered more than 3,000 robots worldwide, according to company head Zhang Guibing. Management wants to increase annual deliveries to 10,000 and establish AiMOGA as a global robotics leader.

The planned listing would place Chery alongside a growing group of Chinese robotics companies seeking access to public capital as investors pour money into the emerging humanoid-robot industry.

Chery is not alone.

Chinese carmakers are increasingly investing in humanoid robots because the technologies involved overlap with automotive manufacturing: electric motors, batteries, sensors, artificial intelligence, precision components and automated production.

For traditional automakers, robotics can therefore provide a way to reuse engineering and manufacturing capabilities developed for vehicles.

Chery established AiMOGA as part of that broader technological strategy.

The company is attempting to develop robots for several commercial applications, including customer service, public guidance, medical support, automotive retail and policing.

That strategy is different from a pure consumer-humanoid approach.

Instead of waiting for robots capable of performing every household task, AiMOGA is targeting controlled environments where relatively specialized machines can begin generating revenue.

One of the company's most visible deployments is its police-robot program.

AiMOGA has put 110 police robots into operation in several Chinese cities, where they are being used for traffic management, public-order guidance and other public-safety tasks.

The company believes such machines could have potential in overseas markets, particularly in regions where governments face labor shortages or harsh operating environments.

Zhang identified the Middle East and Southeast Asia as areas where demand could be particularly strong.

The Middle East could provide applications in security, transportation and public infrastructure, while Southeast Asia has a large and expanding market for service and commercial robotics.

AiMOGA has moved quickly beyond China's domestic market.

The company had surpassed 2,000 cumulative overseas deliveries by late July, with its products and services operating across more than 60 countries and regions. Its international expansion began in Malaysia and later spread into Southeast Asia, the Middle East, Europe, Africa and Latin America.

That global reach is important because Chinese robotics companies are increasingly looking abroad as domestic competition intensifies.

Chery's existing international automobile business gives AiMOGA an advantage that many robotics startups do not have.

The automaker already possesses manufacturing facilities, logistics networks, dealers and local partnerships in numerous countries.

Those resources can potentially help AiMOGA deploy robots faster than a standalone startup would be able to.

AiMOGA's ambition is substantial.

Management wants annual robot output to reach 10,000 units as the business scales.

That would move the company beyond demonstration-stage production and toward a more industrial business.

But scale alone will not determine whether the strategy succeeds.

The economics of humanoid robots remain challenging.

Companies must show that robots can operate reliably, work safely alongside people and perform tasks at a cost competitive with human labor or conventional automation.

China's robotics industry is experiencing enormous enthusiasm, but commercial deployment remains relatively early.

More than 300 robotics companies are participating in the 2026 World Robot Conference in Beijing, displaying thousands of products and launching more than 150 new products.

The sheer number of competitors demonstrates the scale of the opportunity.

It also highlights the risk of overcrowding.

Chinese companies are competing aggressively on price, hardware capability and speed of development. That could eventually drive consolidation, with only the companies that develop strong manufacturing economics and recurring customer demand surviving as global leaders.

Zhang himself has acknowledged that industry consolidation may occur as competition intensifies.

AiMOGA's relationship with Chery provides another important advantage.

The robotics division can draw on the automaker's research, manufacturing, supply-chain, logistics and distribution infrastructure, much of which has been developed through nearly three decades of international automotive operations.

That could become highly valuable if robotics enters a mass-production phase.

Humanoid robots contain numerous components that must be manufactured at consistently high quality and cost.

Automotive companies have extensive experience solving exactly that type of problem.

The advantage is not necessarily that a carmaker can build a better robot immediately.

It is that it may be able to build millions of components efficiently once demand emerges.

AiMOGA has already begun selling robots to consumers in China.

Its humanoid robot is priced at approximately 285,800 yuan, while its quadruped robot dog costs about 15,800 yuan.

Those prices illustrate the industry's current challenge.

A humanoid costing more than $40,000 may be economically viable in some specialized business applications, but it remains expensive for mass household adoption.

The economics could improve as production increases and component costs fall.

That is one reason companies are racing to scale.

AiMOGA sees potential in the United States, but expansion there would depend on regulatory conditions.

That is increasingly important as Washington scrutinizes Chinese robotics technology.

U.S. authorities have raised national-security concerns involving foreign-made humanoid and quadruped robots, and recent regulatory actions could make it more difficult for Chinese manufacturers to access the American market.

For Chery, that creates a strategic challenge.

The company can pursue Europe, Asia, the Middle East, Africa and Latin America, but the United States remains one of the world's largest markets for high-value technology.

If geopolitical restrictions prevent Chinese robots from entering that market, AiMOGA may have to compensate through faster global expansion elsewhere.

Chery has increasingly positioned AiMOGA as a new pillar of its broader business strategy.

The automaker is already a major exporter of vehicles, and robotics provides the potential to diversify its revenue beyond transportation.

That could prove strategically valuable if automotive margins become increasingly competitive.

Robotics also fits into Chery's broader push toward intelligent technologies.

The company can potentially combine AI, mobility, automation and robotics into a wider ecosystem rather than treating the robot unit as a completely separate business.

The potential IPO would give AiMOGA access to capital that could be used for research, manufacturing expansion and international deployment.

The timing is notable.

Chinese investor enthusiasm for robotics has been demonstrated dramatically by Unitree's recent Shanghai listing. Unitree shares surged several hundred percent on their first trading day after an IPO that raised approximately 6.1 billion yuan and attracted extraordinary demand.

That market reception gives Chery a powerful incentive to consider whether public investors are willing to place a significant valuation on a robotics business.

But it also creates a benchmark that will be difficult to match.

The ultimate challenge for AiMOGA, Unitree and their competitors is not publicity.

It is productivity.

Humanoid robots can generate enormous attention when they dance, run or perform acrobatic movements.

Customers, however, will pay for robots that can perform useful tasks consistently.

That means factories, stores, hospitals, logistics centers and public agencies will become the real proving grounds.

If AiMOGA can demonstrate that its robots reduce labor costs, improve safety or operate in environments where human workers are difficult to deploy, demand could expand rapidly.

If those benefits remain difficult to measure, the industry could struggle to justify today's valuations.

AiMOGA's potential IPO therefore comes at a pivotal time.

China has developed one of the world's most aggressive humanoid-robot ecosystems, backed by manufacturing expertise, large domestic capital markets and intense competition among startups and established industrial companies.

Chery is betting that its own manufacturing scale and international distribution network can turn that technology into a global business.

The company's early overseas deliveries and police-robot deployments provide evidence that commercial applications are already emerging.

But the largest opportunity — and the greatest risk — remains ahead.

If robots become economically competitive at scale, Chery could have positioned AiMOGA at the beginning of a new industrial market.

If adoption remains limited, the company will face the same challenge confronting the broader humanoid sector: proving that impressive machines can become profitable businesses.

For now, Chery is preparing to take that bet to public investors.

The potential IPO would not merely finance another robotics startup. It would be a statement that one of China's largest automobile exporters believes humanoid and service robots could become a meaningful growth engine for the company — and potentially one of the next major industries in China's technology economy.